Study the Effect of Danggui Buxue Tang on Menopausal Symptoms
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
This study is to examine the effect and safety of the study drug,Danggui Buxue Tang, on menopausal symptoms of hot flushes and sweating and to determine whether the patient's quality of life will be improved.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Follicle stimulating hormone (FSH), luteinizing hormone (LH), oestradiol in the menopausal range (FSH>18 IU/L, LH>12.6 IU/L, and E2< 361 pmol/l).
Patients with amenorrhoea for more than 12 months
Patients with a history of using any form of hormonal replacement therapy within 8 weeks
Patients with a history of using Chinese medicine or other therapies which may affect the outcome within 8 weeks
Patients who in the judgment of the investigator will be unable to comply with protocol requirements
Patients with significant** gastrointestinal, renal, hepatic, bronchopulmonary, neurological, cardiovascular, breast or endometrial carcinoma, or allergic diseases
Patients with uncontrolled hypertension
Patients with undiagnosed vaginal bleeding
Patients with a history of significant drug hypersensitivity